Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06583122 · ClinicalTrials.gov registry record · NA
Ultrasound Guided Radiofrequency Ablation of the Occipital Nerve
A NA study of Nerve Pain, sponsored by University of Kansas Medical Center.
- Recruiting
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT06583122 is a NA study of Nerve Pain that is actively recruiting participants, run by University of Kansas Medical Center. The registered enrollment target is 20 participants, below the 141-participant average among 4 other Nerve Pain trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06583122, a NA study of Nerve Pain, is actively recruiting participants, sponsored by University of Kansas Medical Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
Study an ultrasound guided approach to radiofrequency ablation of the occipital nerve that makes it possible to see the needle during treatment procedure. It is hoped this will reduce the amount of pain after the standard of care procedure.
Conditions Studied
Interventions
- PROCEDURE Ultrasound Guided Approach
Study Locations (1)
Kansas
- University of Kansas Medical Center - Kansas City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2022-07-01 |
| Est. Completion | 2026-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06583122
The ClinicalTrials.gov registry entry for NCT06583122 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 141-participant average among 4 other Nerve Pain trials with a reported enrollment target (86% lower). The listed sponsor is University of Kansas Medical Center, which has 408 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Nerve Pain appearing as the primary indexed condition, and to 1 intervention - of which Ultrasound Guided Approach is the first listed.
NCT06583122 reports 1 study location spanning 1 distinct geographic area - top geographies include Kansas.
Frequently Asked Questions
What is clinical trial NCT06583122 about?
NCT06583122 is a clinical study titled "Ultrasound Guided Radiofrequency Ablation of the Occipital Nerve". Study an ultrasound guided approach to radiofrequency ablation of the occipital nerve that makes it possible to see the needle during treatment procedure. It is hoped this will reduce the amount of pain after the standard of care procedure.
What is the current status of trial NCT06583122?
This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2022-07-01. Estimated completion is 2026-12-31.
What conditions does trial NCT06583122 study?
This clinical trial studies the following conditions: Nerve Pain.
What interventions are being tested in trial NCT06583122?
The interventions under investigation include: Ultrasound Guided Approach (PROCEDURE).
Who is sponsoring clinical trial NCT06583122?
This trial is sponsored by University of Kansas Medical Center, which has 408 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06583122 being conducted?
This trial has 1 study location across Kansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Nerve Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The Effect of Electroacupuncture on Nerve Pain Caused by Chemotherapy (Chemotherapy-Induced Peripheral Neuropathy)
ACTIVE NOT RECRUITING · NA
-
The Effect of Yoga on Nerve Pain Caused by Chemotherapy (Chemotherapy-Induced Peripheral Neuropathy)
ACTIVE NOT RECRUITING · NA
-
The Effect of Pregabalin on Pain Related to Walking in Patients With Diabetic Peripheral Neuropathy
COMPLETED · Phase 3
-
Trial of Injected Liposomal Bupivacaine vs Bupivacaine Infusion After Surgical Stabilization of Rib Fractures
COMPLETED · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.